Formulation & development
Sikalias Pharmaceutical LaboratoriesFrom an initial brief to formulation strategy, analytical needs, stability work and scale-up planning. Discuss a commissioned development programme.
Start a development enquiry ↗SIKALIAS · SCIENCE, DEVELOPMENT & CARE
R&D, technology transfer, CMO / CDMO and European nearshoring with Sikalias Pharmaceutical Laboratories. Connected to the compounding expertise of Stasinos Sikalias and the pharmacy tradition of Sikalias Pharmacy, established in 1967.
Stasinos Chr. Sikalias
Pharmacist · Managing Director & R&D Manager

SIKALIAS PHARMACEUTICAL LABORATORIES
Development & Contract Manufacturing — CMO / CDMO. Work with the Laboratories on a defined technical and commercial scope.
From an initial brief to formulation strategy, analytical needs, stability work and scale-up planning. Discuss a commissioned development programme.
Start a development enquiry ↗Bring your dossier and manufacturing requirements. Assess process transfer, analytical readiness, batch scale and a defined supply programme.
Discuss technology transfer ↗Explore a European partner for formulation and non-sterile drug-product projects. Technical fit and authorised scope are assessed before a programme is agreed.
Explore a nearshoring project ↗Start with a non-confidential brief: dosage form, development stage, target market, expected volume and timing. Initial contact opens the Laboratories’ project enquiry form. Technical scope, responsibilities and documentation are agreed for each project.
TWO SITES · PERISTERI, GREECE
Sikalias Pharmaceutical Laboratories combines two development and manufacturing sites in Peristeri, including the newly GMP-certified Site 1. The applicable manufacturing scope and technology-transfer requirements are reviewed for each project.
Define formulation options, process needs and the route to an appropriate production scale.
7 Kyklaminon Str., Ag. Ierotheos, Peristeri 12137, Greece
Assess process transfer, batch scale, quality documentation and the authorised scope for the proposed project.
3–5 Stylianou Gonata Str., Industrial Park, Peristeri 12133, Greece
A low-humidity room at Site 1 (<10% RH) supports moisture-sensitive work. Nitrogen-assisted liquid handling is available for assessment where reduced oxygen exposure is relevant. Suitability and operating conditions are determined for each process.
Product stability is established through formulation, packaging and stability studies. Site allocation and backup arrangements are planned with the required technology transfer, validation, approvals and available capacity.
PROJECT FEASIBILITY
Start with the technical question, the intended market and the evidence required. A feasibility review defines the work and the responsibilities.
Explore formulation strategies for existing actives and established dossiers. A new indication or route of administration requires its own scientific and regulatory assessment.
Compare formulation approaches for poorly soluble compounds and define analytical, performance and stability studies. Bioavailability objectives need an appropriate evidence programme.
Discuss formulation needs for orphan and paediatric development programmes, including palatability, stability and flexible batch planning, subject to project qualification and regulatory requirements.
Explore AI-assisted quality workflows and electronic batch-record pilots with QA oversight, data-integrity requirements, validation criteria and human review. Scope and outcomes are defined for each prospective pilot.
SIKALIAS PHARMACY · ESTABLISHED 1967
Sikalias Pharmacy brings together galenical preparation, pharmacist-led support and the continuity of a family pharmacy in Agios Ierotheos, Peristeri. Stasinos Sikalias has led the pharmacy since 1998.
Sikalias Pharmacy accepts compounding enquiries from patients, prescribers and partner pharmacies. Each request is assessed by the pharmacist for feasibility, formulation, preparation records and appropriate use; a prescription is required where applicable.
Compounding at Sikalias Pharmacy ↗7 Kyklaminon Str., Ag. Ierotheos, Peristeri 12137, Greece. Individual preparation and care are discussed directly with the pharmacy.
PATIENTCARE.GR
Practical education on diabetes, medicine routines and adherence, polypharmacy and correct use of self-monitoring devices. Material for patients and caregivers, connected to the pharmacy team.
Explore pharmaceutical care ↗A direct professional route for compounding enquiries and collaboration with the pharmacy laboratory.
lab@sikalias.grExplore the online catalogue, the pharmacy app information and the wider care network.
THE PERSONAL & SCIENTIFIC CONNECTION
A pharmacist whose work connects patient-specific compounding, scientific documentation and industrial formulation development. The same questions of compatibility, stability and practical use connect the pharmacy bench with a development programme.
Systematic specialisation since 2000. Work on preparation quality, documentation and professional education.
Collection and documentation of galenical preparations, edited by Stasinos Sikalias. Current edition and review status at compounding.gr.
Coordinator of the IDEEAF Pharmacy Laboratory Committee, with the 2016 PFS assignment for quality-assurance and formulary work documented in the biography.
Sikalias Pharmaceutical Laboratories handles R&D, technology transfer and manufacturing discussions. The pharmacy provides patient-specific compounding and care. These are distinct professional routes within the ecosystem.
A non-confidential description of the product category, dosage form, development stage, target market, volume and timeline. Detailed confidential formulas and dossiers can follow through an agreed channel.
Contact Sikalias Pharmacy to discuss the request. A pharmacist assesses suitability and feasibility, and any required prescription or prescriber clarification. Availability and timing are confirmed individually.
PatientCare offers educational resources on medicines, diabetes and self-monitoring. Individual guidance is provided through the relevant healthcare professional; these resources do not replace diagnosis or prescribing.
Site 0 connects R&D, pilot work and selected GMP production; Site 1 supports scale-up and manufacturing, including its new GMP certification. Site allocation and any backup production require the applicable authorised scope, technology transfer, validation and capacity assessment.
A low-humidity room at Site 1 (<10% RH) and nitrogen-assisted liquid handling provide process options. Their suitability is assessed for each project. Stability is established through product-specific formulation, packaging and stability studies.
The brands hub at sikalias.eu provides the manufacturer’s product information and collaboration routes for Sikalias® and Kallio®. Product availability and market requirements are assessed through the relevant commercial route.
SIKALIAS ECOSYSTEM
Explore the Laboratories, pharmacy, Formulary, patient care, product brands, educational projects and digital services through one organised directory.